Adrenal myelolipomas in patients with congenital adrenal hyperplasia: Review of the literature and a case report

Endocrine Practice

Volumn 17, Issue 3, 2011, Pages 441-447

  German Mena, Edgar ^a   Zibari, Gazi B ^a   Levine, Steven N ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CORTICOTROPIN; FLUDROCORTISONE; HYDROCORTISONE; HYDROXYPROGESTERONE; PREDNISONE; RENIN; STEROID 21 MONOOXYGENASE; TESTOSTERONE;

ABDOMINAL PAIN; ADIPOSE TISSUE; ADRENAL CORTEX; ADRENAL TUMOR; ADULT; BLOOD PRESSURE; CASE REPORT; CELL LINE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL ADRENAL HYPERPLASIA; CORTICOTROPIN BLOOD LEVEL; ERYTHROID CELL; HEMATOPOIETIC TISSUE; HUMAN; HYPERPIGMENTATION; MALE; MYELOID PROGENITOR CELL; MYELOLIPOMA; NAUSEA; PULSE RATE; REVIEW; TESTOSTERONE BLOOD LEVEL; VOMITING;

EID: 79959655428     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP10340.RA     Document Type: Review

References (48)

1. Gierke E. Uber Knochenmarksgwebe in der Nebenniere. Beitr Path Anat. 1905;(Suppl 7):311-243.
2. Oberling C. Les formations myelolipomatouses. Bull Assoc Fr Etude Cancer. 1929;18:234-236.
3. Kenney PJ, Wagner BJ, Rao P, Heffess CS. Myelolipoma: CT and pathologic features. Radiology. 1998;208:87-95. (Pubitemid 28323314)
4. Patel VG, Babalola OA, Fortson JK, Weaver WL. Adrenal myelolipoma: Report of a case and review of the literature. Am Surg. 2006;72:649-654. (Pubitemid 46940728)
5. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev. 1995;16:460-484.
6. Nieman LK. Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metab. 2010;95:4106-4113.
7. Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356:601-610. (Pubitemid 46220820)
8. Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest. 2006;29:298-302. (Pubitemid 43905318)
9. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149:273-285. (Pubitemid 37304697)
10. Jaresch S, Kornely E, Kley HK, Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1992;74:685-689.
11. Schindler H. Myelolipoma of the adrenal gland in adrenogenital syndrome [article in German]. Wien Med Wochenschr. 1975;725:695-697.
12. Boudreaux D, Waisman J, Skinner DG, Low R. Giant adrenal myelolipoma and testicular interstitial cell tumor in a man with congenital 21-hydroxylase deficiency. Am J Surg Pathol. 1979;3:109-123. (Pubitemid 9148071)
13. Barr AB, Giltman LI. Congenital adrenal hyperplasia diagnosed in an 82-year-old: Case report. Va Med. 1982; 109:844-845.
14. Condom E, Villabona CM, Gómez JM, Carrera M. Adrenal myelolipoma in a woman with congenital 17-hydroxylase deficiency. Arch Pathol Lab Med. 1985; 109:1116-1117. (Pubitemid 16206167)
15. Sasano H, Masuda T, Ojima M, Fukuchi S, Sasano N. Congenital 17 alpha-hydroxylase deficiency: A clinicopathologic study. Hum Pathol. 1987;18:1002-1007. (Pubitemid 17156086)
16. Oliva A, Duarte B, Hammadeh R, Ghosh L, Baker RJ. Myelolipoma and endocrine dysfunction. Surgery. 1988; 103:711-715.
17. Miyazaki Y, Yoshida M, Doi J. A case of adrenal myelolipoma associated with adrenogenital syndrome [Article in Japanese]. Hinyokika Kiyo. 1990;36:35-39.
18. Murakami C, Ishibashi M, Kondo M, et al. Adrenal myelolipoma associated with congenital adrenal 21-hydroxylase deficiency. Intern Med. 1992;31:803-806.
19. Iwamoto T, Yajima M, Tanaka H, Minagawa N, Osada T. A case report: Reversible male infertility due to congenital adrenal hyperplasia [Article in Japanese]. Nippon Hinyokika Gakkai Zasshi. 1993;84:2031-2034. (Pubitemid 24013911)
20. Ravichandran R, Lafferty F, McGinniss MJ, Taylor HC. Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: Report of two patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1996;81:1776-1779. (Pubitemid 26152462)
21. Umpierrez MB, Fackler S, Umpierrez GE, Rubin J. Adrenal myelolipoma associated with endocrine dysfunction: Review of the literature. Am J Med Sci. 1997;314:338-341. (Pubitemid 27481532)
22. Parenteau C, Mongeau CJ, Bénard B, Maheux P. Pigmented adrenal hyperplasia with myelolipomatous changes and bilateral testicular enlargement in an untreated man with 21-hydroxylase deficiency. Endocr Pract. 2000;6: 260-263.
23. Nagai T, Imamura M, Honma M, Murakami M, Mori M. 17alpha-hydroxylase deficiency accompanied by adrenal myelolipoma. Intern Med. 2001;40:920-923.
24. Allison KH, Mann GN, Norwood TH, Rubin BP. An unusual case of multiple giant myelolipomas: Clinical and pathogenetic implications. Endocr Pathol. 2003;14:93-100. (Pubitemid 36605687)
25. Bhansali A, Dash RJ, Singh SK, Behra A, Singh P, Radotra BD. Adrenal myelolipoma: Profile of six patients with a brief review of literature. Int J Endocrinol Metab. 2003; 1:33-40.
26. Patocs A, Liko I, Varga I, et al. Novel mutation of the CYP17 gene in two unrelated patients with combined 17alpha-hydroxylase/17,20-lyase deficiency: Demonstration of absent enzyme activity by expressing the mutant CYP17 gene and by three-dimensional modeling. J Steroid Biochem Mol Biol. 2005;97:257-265. (Pubitemid 41607576)
27. Kalidindi RS, Hattingh L. Bilateral giant adrenal myelolipomas. Abdom Imaging. 2006;31:125-127. (Pubitemid 43081653)
28. Mathew J, Menon PS, Shah NS. An elderly lady in shock. J Postgrad Med. 2005;51:51-53. (Pubitemid 40976038)
29. Treska V, Wirthová M, Hadravská S, et al. Giant bilateral adrenal myelolipoma associated with congenital adrenal hyperplasia. Zentralbl Chir. 2006;131:80-83. (Pubitemid 43324656)
30. Sakaki M, Izaki H, Fukumori T, Taue R, Kishimoto T, Kanayama HO. Bilateral adrenal myelolipoma associated with adrenogenital syndrome. Int J Urol. 2006;13:801-802. (Pubitemid 43926776)
31. Rajput, R, Bhansali, A, Khanderwal, N, Das Radotra B. Evolution of adrenal myelolipoma in a patient with congenital adrenal hyperplasia. Endocrinologist. 2007;17:200-201. (Pubitemid 47220769)
32. Hagiwara H, Usui T, Kimura T, et al. Lack of ACTH and androgen receptor expression in a giant adrenal myelolipoma associated with 21-hydroxylase deficiency. Endocr Pathol. 2008;19:122-127.
33. Nigawara T, Kageyama K, Sakihara S, et al. A male case of nonclassical 21-hydroxylase deficiency first manifested in his sixties with adrenocortical incidentaloma. Endocr J. 2008;55:291-297. (Pubitemid 351670953)
34. John M, Menon SK, Shah NS, Menon PS. Congenital adrenal hyperplasia 11beta-hydroxylase deficiency: Two cases managed with bilateral adrenalectomy. Singapore Med J. 2009;50:e68-e70.
35. Nermoen I, Følling I, Vegge K, et al. Two adults with adrenal myelolipoma and 21-hydroxylase deficiency. Case Report Med. 2009;2009:916891.
36. Mermejo LM, Elias Junior J, Saggioro FP, et al. Giant adrenal myelolipoma associated with 21-hydroxylase deficiency: Unusual association mimicking an androgen-secreting adrenocortical carcinoma. Arq Bras Endocrinol Metabol. 2010;54:419-424.
37. Peppa M, Dracopoulou-Vabouli M, Raptis SA. Bilateral adrenal myelolipomas associated with 21-hydroxylase deficiency. Endocr Pract. 2010;16:525-526.
38. Lamas C, López LM, Lozano E, et al. Myelolipomatous adrenal masses causing Cushing's syndrome. Exp Clin Endocrinol Diabetes. 2009;117:440-445.
39. Hisamatsu H, Sakai H, Tsuda S, Shigematsu K, Kanetake H. Combined adrenal adenoma and myelolipoma in a patient with Cushing's syndrome: Case report and review of the literature. Int J Urol. 2004;11:416-418. (Pubitemid 38858940)
40. Ukimura O, Inui E, Ochiai A, Kojima M, Watanabe H. Combined adrenal myelolipoma and pheochromocytoma. J Urol. 1995;154:1470.
41. Sun X, Ayala A, Castro CY. Adrenocortical carcinoma with concomitant myelolipoma in a patient with hyperaldosteronism. Arch Pathol Lab Med. 2005; 129: E144-e147.
42. Selye H, Stone H. Hormonally induced transformation of adrenal into myeloid tissue. Am J Path. 1950;26:211-233.
43. Turton DB, O'Brian JT, Shakir KM. Incidental adrenal nodules: Association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone. J Endocrinol Invest. 1992;15:789-796. (Pubitemid 23060028)
44. Bernini GP, Brogi G, Vivaldi MS, et al. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas. J Endocrinol Invest. 1996;19:745-752. (Pubitemid 27073140)
45. Seppel T, Schlaghecke R. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas'). Clin Endocrinol (Oxf). 1994;41:445-451.
46. Tóth M, Rácz K, Adleff V, et al. Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy. J Endocrinol Invest. 2000; 23:287-294. (Pubitemid 30426547)
47. Patócs A, Tóth M, Barta C, et al. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas. Eur J Endocrinol. 2002;147:349-355.
48. Baumgartner-Parzer SM, Pauschenwein S, Waldhäusl W, et al. Increased prevalence of heterozygous 21-OH germline mutations in patients with adrenal incidentalomas. Clin Endocrinol (Oxf). 2002;56:811-816. (Pubitemid 34785915)